INS and Hyperinsulinemia: Similarly CRMP slows E0771 tumor growth, similar to its effect to slow colon tumor growth [35], by reversing hyperinsulinemia and insulin-dependent increases in tumor glucose uptake and oxidation, without any direct effect to alter tumor cell metabolism or division.